We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bristol-Myers Squibb

News List

Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer americanpharmaceuticalreview
January 22, 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Bristol-Myers Squibb and GeneCentric Diagnostics announce exploratory biomarker research collaborati worldpharmanews
January 11, 2017
Bristol-Myers Squibb Company (NYSE:BMY) and GeneCentric Diagnostics, Inc. have announced a biomarker research collaboration...
Janssen and Bristol-Myers Squibb to Evaluate DARZALEX® in Combination with OPDIVO® americanpharmaceuticalreview
January 06, 2017
Janssen Biotech has entered a clinical trial collaboration with Bristol-Myers Squibb Company to evaluate the combination of the first CD38-directed cytolytic antibody daratumumab (DARZALEX®) and checkpoint inhibitor nivolumab (OPDIVO®) in Phase 1b/Phase 2

Previous page 1 2 3 4 5 6 7 8 9 10 Next page